Mario N. Lioubin
Mario N. Lioubin publishes mostly in Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism, on topics such as TGF-β signaling in diseases, Viral Infectious Diseases and Gene Expression in Insects and Growth Hormone and Insulin-like Growth Factors.
- World rank
- #572,463 of 7,710,434 ranked researchers
- Rank in United States
- #197,247 of 1,627,098
- Works
- 31
- Citations
- 3.6k
- Citations per work
- 117.7
What does Mario N. Lioubin research?
Mario N. Lioubin's work is mostly in Biochemistry, Genetics and Molecular Biology (49%), Medicine (27%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1857.4%
- Health Sciences927.5%
- Medicine927.5%
- Everything else515.1%
- 1Molecular Biology44% of their works
- 2Oncology10% of their works
- 3Endocrinology, Diabetes and Metabolism9% of their works
- 4Immunology8% of their works
- 5Radiology, Nuclear Medicine and Imaging8% of their works
- 6Genetics6% of their works
Research topics
- TGF-β signaling in diseases
- Viral Infectious Diseases and Gene Expression in Insects
- Growth Hormone and Insulin-like Growth Factors
- Monoclonal and Polyclonal Antibodies Research
- Cancer-related gene regulation
- Animal Genetics and Reproduction
- Glycosylation and Glycoproteins Research
- Cytokine Signaling Pathways and Interactions
Which keywords describe Mario N. Lioubin's research?
The keywords of their largest research topics: Cancer, Glycosylation, Immune Response, Biopharmaceutical Production, Smad-dependent pathways, Tumor Suppression, Mammalian Cells and Recombinant Protein.
- Transgenic Animals
- Immune System
- Glycans
- Protein Arginine Methyltransferases
- Therapeutic Antibodies
- Insulin-like Growth Factors
- Recombinant Protein
- Tumor Suppression
- Biopharmaceutical Production
- Glycosylation
- Cancer
- Immune Response
- Smad-dependent pathways
- Mammalian Cells
- IGF-1
- Fc Receptors
- Arginine Methylation
- Genetic Modification
- IL-6
- STAT3
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cancer204 topics
- Glycosylation193 topics
- Immune Response142 topics
- Biopharmaceutical Production122 topics
- Smad-dependent pathways111 topic
- Tumor Suppression111 topic
- Mammalian Cells91 topic
- Recombinant Protein91 topic
- IGF-181 topic
- Insulin-like Growth Factors81 topic
- Fc Receptors71 topic
- Therapeutic Antibodies71 topic
- Arginine Methylation61 topic
- Protein Arginine Methyltransferases61 topic
- Genetic Modification31 topic
- Glycans31 topic
- IL-631 topic
- Immune System31 topic
- STAT331 topic
- Transgenic Animals31 topic
Where does Mario N. Lioubin work?
Mario N. Lioubin's main affiliation in the publication record is OncoGenex Pharmaceuticals (United States), United States.
How many publications and citations does Mario N. Lioubin have?
OpenAlex counts 31 works and 3,649 citations for Mario N. Lioubin, an h-index of 24, ranking #572,463 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mario N. Lioubin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.